Amiodarone and optic neuropathy

American Heart Journal

Volumn 156, Issue 3, 2008, Pages 411-413

  Mindel, Joel S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

DIFFERENTIAL DIAGNOSIS; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; ISCHEMIC OPTIC NEUROPATHY; MALPRACTICE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; INCIDENCE; OPTIC NERVE DISEASES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 49949087409     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.05.007     Document Type: Editorial

References (28)

1. Petri Jr. W.A. Chapter 47, Chemotherapy of tuberculosis, Mycobacterium avium complex disease and leprosy. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (2006), McGraw-Hill, New York 1210
2. Cullen J.F. Ischemic optic neuropathy. Trans Ophthalmol Soc UK 87 (1967) 759-774
3. Miller G.R., and Smith J.L. Ischemic optic neuropathy. Am J Ophthalmol 62 (1966) 103-115
4. The Ischemic Optic Neuropathy Decompression Trial Research group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAIDN) is not effective and may be harmful. JAMA 273 (1995) 625-632
5. Hayreh S.S., Zimmerman M.B., Podhajsky P., et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117 (1994) 603-624
6. Palombi K., Renard E., Chiquet C., et al. Non-arteritic anterior ischemic optic neuropathy is nearly systematically associated with obstructive sleep apnea. Br J Ophthalmol 90 (2006) 879-882
7. Weger M., Haas A., Stanger O., et al. Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy. Ophthalmology 109 (2002) 749-752
8. Salomon O., Rosenburg N., Steinberg D.M., et al. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein 1bα gene. Ophthalmology 111 (2004) 184-188
9. Weger M., Stanger O., Deutschmann H., et al. Hyperhomocyst (e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol 85 (2001) 803-806
10. Mansour A.M., Shoch D., and Logani S. Optic disc size in ischemic optic neuropathy. Am J Ophthalmol 106 (1988) 587-589
11. Modarres M., Sanjari M.S., and Falavarjani K.G. Vitrectomy and release of presumed epipapillary vitreous traction for treatment of nonarteritic ischemic optic neuropathy associated with partial posterior vitreous detachment. Ophthalmology 114 (2007) 340-344
12. Feiner L.A., Younge B.R., Kazmier F.J., et al. Optic neuropathy and amiodarone therapy. Mayo Clin Proc 62 (1987) 702-717
13. Johnson L.N., Krohel G.B., and Thomas E.R. The clinical spectrum of amiodarone induced optic neuropathy. J Natl Med Assoc 96 (2004) 1477-1491
14. Stelfox H.T., Ahmed S.B., Fiskio J., et al. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther 75 (2004) 110-122
15. Johnson L.N., and Arnold A.C. Incidence of non-arteritic and arteritic anterior ischemic optic neuropathy: population based study in the state by Missouri and Los Angeles County, California. J Neuroophthalmol 14 (1994) 38-44
16. Hattenbauer M.G., Leavitt J.A., Hodge D.O., et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123 (1997) 103-107
17. Castella D.D., Teitelbaum B.A., and Tresley D.J. Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy. Optometry 73 (2002) 113-121
18. Nagra P.K., Foroozan R., Savino P.J., et al. Amiodarone-induced optic neuropathy. Br J Ophthalmol 87 (2003) 420-422
19. Purvin V., Kawasaki A., and Borraut F.X. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 124 (2006) 696-701
20. Mindel J.S., Anderson J., Helikamp A., et al. Absence of bilateral visual loss from amiodarone: a randomized trial. Am Heart J 153 (2007) 837-842
21. Ellenberger Jr. C., Keltner J.L., and Burde R.M. Acute optic neuropathy in older patients. Arch Neurol 28 (1973) 182-185
22. Hayreh S.S., and Zimmerman B. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology 114 (2007) 1763-1772
23. Morrissey S.P., Borraut F.X., Miller D.H., et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry 58 (1995) 70-74
24. Jacobson D.M., Vierkant R.A., and Belongia E.A. Nonarteritic anterior ischemic optic neuropathy: a case-control study of potential risk factors. Arch Ophthalmol 115 (1997) 1403-1407
25. Hayreh S.S., Joos K.M., Podhajsky P.A., et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118 (1994) 766-780
26. Bardy G.H., Lee K.L., Mark D.P., et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
27. Harris M.I., Flegal K.M., Cowie C.C., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. Diabetes Care 21 (1998) 518-524
28. Fields L.E., Birt V.L., Cutler J.A., et al. The burden of adult hypertension in the United States. A rising tide. Hypertension 44 (2004) 398-404